Please login to the form below

cobicistat

This page shows the latest cobicistat news and features for those working in and with pharma, biotech and healthcare.

Positive trial results for Janssen’s Symtuza boosts its HIV credentials

The STR provided ‘effective’and ‘durable’viral suppression. Janssen’s darunavir-based single tablet regimen (STR) Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) showed a positive outcome in the treatment of HIV

Latest news

Janssen wins European approval for Symtuza

It’s the first complete, single-tablet regimen (STR) based on its big-selling protease inhibitor Prezista (darunavir), which it combines with cobicistat, emtricitabine and tenofovir alafenamide (TAF).
CHMP backs three immuno-oncology drugs for solid tumours

The once-daily product combines darunavir with cobicistat, emtricitabine and tenofovir alafenamide (TAF) and is vying to compete with therapies from GlaxoSmithKline's ViiV unit.
Gilead plans fightback against HIV arch-rival ViiV

its Genvoya and Stribild products - which needs to be boosted with cobicistat.
ViiV takes two-drug cocktail for first-line HIV into phase III

HIV therapies that combine multiple drugs into one tablet such as ViiV's Triumeq (dolutegravir/abacavir/lamivudine) and Gilead's Quad product (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) are expected to be
Gilead gets EU nod for TAF-based triple therapy for HIV

also bagged approval for four-drug Genvoya (elvitegravir, emtricitabine, cobicistat and TAF), an updated version of the company's $1.8bn Stribild brand.

More from news
Approximately 7 fully matching, plus 31 partially matching documents found.

Featured jobs

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Programme Executive: Salary TBC

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior Account Manager / Account Director: Great salary and bebefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Account Manager – Med Comms – Kent: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Senior Account Manager or AD - Medical Communications: Salary TBC

Scientific Director: Great salary and bebefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editorial Director – Medical Education – Oxford: Negotiable

Senior Medical Writer: Great salary and bebefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Medical Writer - (London, Brighton or Copenhagen): Competitive

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Medical Writer: Great salary and benefits

Editor – Medical Education Agency – Bucks: Salary TBC

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Subscribe to our email news alerts

PMHub

Add my company

Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...